USask researchers to start clinical trials for new Alzheimer’s drug

NeuroEPO, a drug studied in early Alzheimer's patients, is being advanced. The USask team is working with Saskatoon organizations to recruit participants.

source https://globalnews.ca/news/9474388/usask-clinical-trials-alzheimers-treatment/